Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Long-acting fluorine-containing prostaglandins for ocular diseases

Oct. 7, 1998

Phase II trial commences of AG-3340 in AMD

Sep. 17, 1998

Phase II testing of ISV-205 begins for glaucoma

Sep. 14, 1998

Micrologix Biotech advances development of antimicrobial peptides for treatment of eye infections

Sep. 14, 1998

Troponin I blocks retinal angiogenesis in another animal model

Sep. 11, 1998

IND application for NeXstar antiangiogenesis drug approved by FDA

Sep. 4, 1998

PMA for KeraVision Ring accepted for filing

Sep. 3, 1998

IL-1 blockers CK-119 and CK-122 inhibit corneal fibroblast-like cell proliferation

Aug. 28, 1998

Future antiglaucoma drug candidates added to the pipeline at Alcon

Aug. 24, 1998

PGF2alpha derivative from Allergan reduces ocular hypertension in monkeys

Aug. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...